Share This Post

Expert Discusses Immunotherapy Combos in Kidney Cancer

From Curetoday

Immunotherapy combinations are showing potential for treating patients who have renal cell carcinoma (RCC), according to Robert J. Motzer, M.D., a medical oncologist at Memorial Sloan Kettering Cancer Center. “I am quite optimistic that these combinations will change our approach to kidney cancer in the first-line setting for years to come,” says Motzer.

Read the full article here.

 

 

 

 

 

Share This Post

Profile photo of Dena Battle
Dena Battle is the President of KCCure. She also serves on the Advisory Board for the Johns Hopkins Sidney Kimmel Cancer Center and as a member of the Patient and Family Advisory Council.

Lost Password

Register

Subscribe for updates!